Trademark Details For ACCUCAINE (Serial Number 86955208)

  •  Home
  •  Print
ACCUCAINE
0
0
0
0
word.basic_information
Serial Number  United States - USPTO 86955208
Registration Number 5347041
Mark
ACCUCAINE
Filing Date Mar-28-2016
Status
Registered  
SECTION 8 & .. (702)
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
Attorney Name
TTAB
0
Action Tags
  


  • ASCLEMED USA, INC.


005Pharmaceuticals

U.S Class(es): 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jun-28-2016

First Use in Commerce: Jun-28-2016





Correspondences

NameIrene Y. Lee
AddressRuss, August & Kabat 12424 Wilshire Blvd., Suite 1200 Los Angeles,CA 90025

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Mar-31-2016NEW APPLICATION ENTERED   NWAPI
Mar-31-2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Jul-11-2016ASSIGNED TO EXAMINER   DOCKD
Jul-11-2016APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Jul-27-2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Aug-16-2016PUBLISHED FOR OPPOSITION   PUBOA
Aug-16-2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Oct-11-2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jan-18-2017TEAS CHANGE OF CORRESPONDENCE RECEIVED   TCCAI
Mar-31-2017SOU TEAS EXTENSION RECEIVED   EEXTI
Mar-31-2017SOU EXTENSION 1 FILED   EXT1S
Mar-31-2017SOU EXTENSION 1 GRANTED   EX1GS
Apr-04-2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Sep-25-2017TEAS STATEMENT OF USE RECEIVED   EISUI
Oct-03-2017CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Sep-25-2017USE AMENDMENT FILED   IUAFS
Oct-05-2017STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Oct-24-2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Oct-25-2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Nov-28-2017REGISTERED-PRINCIPAL REGISTER   R.PRA
Nov-28-2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Jan-30-2023TEAS SECTION 8 & 15 RECEIVED   E815I
Jul-25-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jul-25-2023
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
  
PR23O
Jan-18-2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED   EROPI
Feb-01-2024
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
  
PR23O
Feb-01-2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED   EROPI
Feb-06-2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Feb-06-2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E